VERSANT VENTURE MANAGEMENT, LLC

VERSANT VENTURE MANAGEMENT, LLC is a Seed, Series A, Series B and Series C+ fund in the US, Canada and Europe writing $1M–$50M checks into Healthcare, biotechnology, drug-discovery, drug-development, small-molecules, biologics, macrocyclic-peptides, immunology, oncology, autoimmune-disease, drug-delivery, medical-devices, diagnostics, healthcare-it, precision-medicine, biomarkers and platform-technologies.

Stages: Seed, Series A, Series B, Series C+
Sectors: Healthcare, biotechnology, drug-discovery, drug-development, small-molecules, biologics, macrocyclic-peptides, immunology, oncology, autoimmune-disease, drug-delivery, medical-devices, diagnostics, healthcare-it, precision-medicine, biomarkers, platform-technologies
Check size: $1M–$50M
Invests in: US-wide, Canada, Europe
Actively investing: Yes
Founded: 1999
Assets under management: $4.2B-$5.5B
Website: versantventures.com

Thesis

Versant's investment thesis centers on partnering with academic founders and experienced biotech teams to transform scientific discoveries into commercial enterprises. The firm combines scientific expertise with operational excellence to accelerate therapeutic and diagnostic innovations. Versant leverages in-house discovery engines to de-risk company creation and accelerate the time to clinic. The firm invests across all stages, from seed through post-IPO, and typically leads or co-leads rounds. Versant deploys half their funds towards outside companies and half to developing companies in-house. Versant manages between $4.2 billion and $5.5 billion in assets under management.

Common questions

Does VERSANT VENTURE MANAGEMENT, LLC invest at the Seed stage?

Yes. VERSANT VENTURE MANAGEMENT, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.

What check size does VERSANT VENTURE MANAGEMENT, LLC write?

VERSANT VENTURE MANAGEMENT, LLC writes $1M–$50M checks.

Where does VERSANT VENTURE MANAGEMENT, LLC invest?

VERSANT VENTURE MANAGEMENT, LLC invests in the US, Canada and Europe.